CureMatch CEO Blaise Barrelet Featured in Rancho Sante Fe Review

Rancho Santa Fe Review article discusses CureMatch CEO Blaise Barrelet’s personal battle with cancer, and why he decided to found CureMatch.

Launch of CureMatch Certified Precision Oncology Recognition Award
CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...
CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment
CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...
CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments
CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...
The Complex Cancer Puzzle | Video 1
ShareLinkedInFacebookTwitterRedditEmailPrint
CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments
CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues....
CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service
Oncologists will be able to submit claims to payers using a Category III CPT code,...
CureMatch CEO Navid Alipour named a Top 50 Honoree Leader of Influence in Life Science by San Diego Business Journal
Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in...